Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

Tarun Garg, Goutam Rath, Amit K. Goyal

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

The aim of this study was to prepare and characterize spray dried inhalable chitosan nanoparticles (CNPs) for sustained delivery of anti-tubercular drugs, isoniazid (INH) and rifampicin (RIF), to the lungs. CNPs were prepared by ionic gelation technique followed spray drying. Results showed that the CNPs obtained had a smooth spherical shape with an average size of 230 ± 4.5 nm, with a poly dispersity index of 0.180 ± 0.021. Both drugs, were detected in various organs (lungs, liver, spleen and kidney) until 24 h post nebulization. The chemotherapeutic efficacy of a single dose of drug-loaded CNPs suggested that they are more effective against the mycobacterium than free drugs.
Original languageEnglish (US)
Pages (from-to)997-1001
Number of pages5
JournalArtificial Cells, Nanomedicine and Biotechnology
Volume44
Issue number3
DOIs
StatePublished - Apr 2 2016
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Biomedical Engineering
  • Pharmaceutical Science
  • Medicine (miscellaneous)

Fingerprint

Dive into the research topics of 'Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis'. Together they form a unique fingerprint.

Cite this